In vitro inhibition of cell proliferation, viability, and invasiveness in U87MG human glioblastoma cells by estramustine phosphate

Neurosurgery

Volumn 39, Issue 2, 1996, Pages 360-366

  Yoshida, Daizo ^a   Piepmeier, Joseph M ^a   Teramoto, Akira ^b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell migration; Cell proliferation; Estramustine phosphate; Glioblastoma; Matrigel

Indexed keywords

ANTINEOPLASTIC AGENT; ESTRAMUSTINE PHOSPHATE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CELL DIVISION; CELL LINE; CELL MOVEMENT; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRAMUSTINE; GLIOBLASTOMA; HUMANS; NEOPLASM INVASIVENESS; TUMOR CELLS, CULTURED;

EID: 0029939720     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199608000-00025     Document Type: Article

References (73)

1. Abe T, Mori T, Kohno K, Sciki M, Hayakawa T, Welgus H, Hori S, Kuwano M: Expression of 72 kDa Type IV collagenase and invasion activity of human glioma cells. Clin Exp Metastasis 12:296-304, 1994.
2. Albini A, Iwamoto Y, Kleinman H, Martin G, Aaronson S, Kozlowski J, McEwan R: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239-3245, 1987.
3. Anderson D, Hughes B, VVible L, Perry G, Smith C, Brinkley B: Impaired motility of neonatal PMN leukocytes: Relationship to abnormalities of cell orientation and assembly of microtubules in chemotactic gradients. J Leukocyte Biol 36:1-15, 1984.
4. Barna B, Estes M, Jacobs B: Human astrocytes proliferate in response to tumor necrosis factor alpha. J Neuroimmunol 30:239-243, 1990.
5. Bergenheim A, Björk P, Bergh J, von Schoultz E, Svedberg H, Henriksson R: Eslramustine binding and specific binding of the antimitotic compound estramustine in astrocytoma. Cancer Res 54:4974-4979, 1994.
6. Bergenheim A, Gunnarsson P, Edman K, von Schoultz E, Hariz M: Uptake and retension of estramustine and presence of estramustine-binding protein in malignant brain rumours in humans. Br J Cancer 67:358-361, 1993.
7. Bernstein JJ, Laws ER Jr, Levine KV, Wood LR, Tadvalkar G, Golgberg WJ: C6 glioma-astrocytoma cells and fetal astrocyte migration into artificial basement membrane: A permissive substrate for neural tumors but not fetal astrocytes. Neurosurgery 28:652-658, 1991.
8. Bishop M, de la Monte SM: Dual lineage of astrocytomas. Am J Pathol 135:517-527, 1989.
9. Bloom G, Schoenfeld T, Vallee R: Widespread distribution of the major polypeptide component of MAP 1 (microtubule-associated protein 1). J Cell Biol 98:320-330, 1984.
10. Bohn W, Roser K, Hochenberg H, Mannweiler K, Traub P: Cytoskeleton architecture of C6 rat glioma cell subclones differing in intermediate filament protein expression. J Struct Biol 111:48-58, 1993.
11. Cameron R, Rakic P: Identification membrane proteins that comprise the plasmalemmal junction between migrating neurons and radial grial cells. J Neurosci 14:3139-3155, 1994.
12. Connolly J, Kalnins V: The distribution of tau and HMW microtubule-associated proteins in different cell types. Exp Cell Res 127:341-350, 1980.
13. Coomber B: Cytoskeleton in TGF-beta- and bFGF-modulated endothelial monolayer repair. Exp Cell Res 194:42-47, 1991.
14. Cornell-Bell A, Thomas P, Smith S: The excitatory neurotransmitter glutamate causes filopodia formation in cultured hippocampal astrocytes. Glia 3:322-334, 1990.
15. Couchie D, Charrière-Bertrand C, Nunez J: Expression of the mRNA for tau proteins during brain development and in cultured neurons and astroglial cells. J Neurochem 50:1894-1899, 1988.
16. Dahllof B, Billstrom A, Cabrai F, Hartley-Asp B: Estramustine depolymerizes microtubules by binding to tubulin. Cancer Res 53:4573-4581, 1993.
17. Dinsdale C, Mirza F, Wiebe J: Glycerol alters cytoskeleton and cell adhesion while inhibiting cell proliferation. Cell Biol Int 16:591-602, 1992.
18. Djakiew D, Pflug B, Delsite R, Onoda M, Lynch J, Arand R, Thompson E: Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor-like protein. Cancer Res 53:1416-1420, 1993.
19. Engstrom K, Grankvist K, Henriksson R: Early morphological detection of estramustine cytotoxicity measured as alteration in cell size and shape by a new technique of microperifusion. Eur J Cancer 27:1288-1295, 1991.
20. Errante L, Wiche G, Shaw G: Distribution of pletin, an intermediate filament-associated protein, in the adult rat central nervous system. J Neurosci Res 37:515-528, 1994.
21. Forsgren B, Björk P: Specific binding of estramustine to prostatic proteins. J Urol 23:31-38, 1984.
22. Gadisseux J, Giffinet A, Lyon G, Evrard P: The human transient subpial granular layer: An optical, immunohislochemical, and ultrastructural analysis. J Comp Neurol 324:94-114, 1992.
23. Garner C, Brugg B, Matus A: A 70-kilodalton microtubuleassociated protein (MAP2c), related to MAP2. J Neurochem 50:609-615, 1988.
24. Giambanco I, Sorci G, Antonioli S, Rambotti M, Spreca A, Bocchini V, Donato R: Immunocytochemical analyses of annexin V (CaBP33) in a human-derived glioma cell line. Expression of annexin X depends on cellular growth state. FEBS Lett 323:45-50, 1993.
25. Giese A, Rief M, Loo M, Berens M: Determinants of human astrocytoma migration. Cancer Res 54:3897-3904, 1994.
26. Gunnarsson P, Andersson S-B, Sandeberg A, Ellman M: Accumulation of estramustine and estromustine in adipose tissue of rats and humans. Cancer Chemother Pharmacol 28:361-364, 1991.
27. Han J, Daniel J, Papas G: Expression of Type VI collagen during glioblastoma cell invasion in brain tissue culture. Cancer Lett 88:127-132, 1995.
28. Hartley-Asp B: Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines, DU 145 and PC-3. Prostate 5:93-100, 1984.
29. Hoshi M, Akiyama T, Shinohara Y, Ogawara H, Nishida E, Sakai H: Protein kinase C-catalyzed phosphorylation of the microtubule-binding domain of microtubule-associated protein 2 inhibits its ability to induce tubulin polymerization. Eur J Biochem 174: 225-230, 1988.
30. Hudes G, Greenberg R, Kriegel R, Fox S, Scher R, Litwin S, Watts P, Speicher L, Tew K, Comis R: Phase 2 study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer. J Clin Oncol 10:1754-1761, 1992.
31. Iwasaki K, Rogers L, Barnett G, Estes M, Barna B: Effect recombinant tumor necrosis factor-α on three-dimensional growth, morphology, and invasiveness of human glioblastoma cells in vitro. J Neurosurg 78:952-958, 1993.
32. Janiak M, Hashimi H, Janowska-Wiexzorek A: Use of the Matrigelbased assay to measure the invasiveness of leukemic cells. Exp Hemalol 22:559-569, 1994.
33. Jordan J, Hand C, Markowitz R, Black P: Test for chemotherapeutic sensitivity of cerebral gliomas: Use of colorimetric MTT assay. J Neurooncol 14:19-35, 1992.
34. Kalland T, Haukaas S: Immunologic effects of estramustine phosphate. Urology 23:39-45, 1984.
35. Kanje M, Deinum J, Wallin M, Ekstrom P, Edstrom A, Hartley-Asp B: Effect of estramustine phosphate on the assembly of isolated bovine brain microtubules and fast axonal transport in the frog sciatic nerve. Cancer Res 45:2234-2239, 1985.
36. Kim J, Khil M, Ryu S, Gabel M: Clinical and biological studies of estramustine phosphate as a radiation sensitizer. Int J Radiat Oncol Biol Phys 29:555-557, 1994.
37. Lin C, Forscher P: Cytoskeleton remodeling during growth cone-target interactions. J Cell Biol 121:1369-1383, 1993.
38. Mareel M, Storme G, Dragonetti C, DeBruyne G, Hartley-Asp B, Segers J, Rabaey M: Anti-invasive activity of estramustine on malignant MO4 mouse cells and on DU-145 human prostate carcinoma cells in vitro. Cancer Res 48:1842-1849, 1988.
39. Maria B, Cumming R, Sukhu L: Crown of microfilaments in the extending cytoplasmic processes of medulloblastoma glial progenitors. Can J Neurol Sci 19:23-33, 1992.
40. Merzak A, Koocheckpour S, Pilkington G: CD44 mediates human cell adhesion and invasion in vitro. Cancer Res 54:3988-3992, 1994.
41. Mohanam S, Sawaya R, McCutcheon I, Ali-Osman F, Boyd D, Rao J: Modulation of in vitro of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res 53:4143-4147, 1993.
42. Moraga D, Rivas-Berrios A, Farías G, Wallin M, Maccioni R: Estramustine-phosphate binds to a tubulin binding domain on microtubule-associated proteins MAP-2 and tau. Biochem Biophys Acta 1121:97-103, 1992.
43. Muir D, Sukhu L, Johnson J, Lahorra M, Maria B: Quantitative methods for scoring cell migration and invasion in filter-based assays. Anal Biochem 215:104-109, 1993.
44. Nikkahah G, Tonn J, Hoffmann O, Kraemer H, Darling J, Schonmayr R, Schachenmayr W: The MTT assay for chemosensitivity testing of human tumors of the central nervous system. J Neurooncol 13:1-11, 1992.
45. Oelschlaeger T, Guerry P, Kopecko D: Unusual microtubuledependent endocytosis mechanisms triggered by Campylobactcr jejwii and Citrobacter freundi. Proc Natl Acad Sci U S A 90:68846888, 1993.
46. Ohnishi T, Arita N, Hayakawa T, Kawahara K, Kato K, Kakinuma A: Purification of motility factor (GMF) from human malignant glioma cells and its biological significance in tumor invasion. Biochem Biophys Res Commun 193:518-525, 1993.
47. Ohsugi M, Ohsawa T, Yamamura H: Involvement of protein kinase C in nuclear migration during compaction and the mechanism of the migration: Analysis in two-cell mouse embryos. Dev Biol 156:146-154, 1993.
48. Oliver S, Banquerigo M, Brahn E: Suppression of collageninduced arthritis using angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, taxol. Cell Immunol 157:291-299, 1994.
49. Paulus W, Tonn J: Basement membrane invasion of glioma cells mediated by integrin receptors. J Neurosurg 80:515-519, 1994.
50. Pavelic J, Zgradic I, Pavelic K: Presence of oestrogen receptors on target cells and antiproliferative activity of estramustine phosphate: Positive correlation for human tumours in vitro. J Cancer Res Clin Oncol 117:244-248, 1991.
51. Piepmeier J, Keefe D, Weinstein M, Yoshida D, Zielinski J, Lin T, Chen Z, Nafiolin F: Estramustine and estrone analogs rapidly and reversibly inhibit deoxyribonucleic acid synthesis and alter morphology in cultured human glioblastoma cells. Neurosurgery 32:422-431, 1993.
52. Riederer B: Differential phosphorylation of some proteins of the neuronal cytoskeleton during brain development. Histochem J 24:783-790, 1992.
53. Rutberg M, Wallin M: Estramustine induces disorganization of microtubules, perinuclear retraction of vimentin and endoplasmic reticulum, and inhibits cell migration. Acta Histochem 95:155-167, 1993.
54. Ryu S, Gabel M, Khil M, Lee Y, Kim S, Kim J: Estramustine: A novel radiation enhancer in human carcinoma cells. Int J Radiat Oncol Biol Phys 30:99-104, 1994.
55. Sahenk Z, Mendell J: Alteration in slow transport kinetics induced by estramustine, an agent binding to microtubule-associated proteins. J Neurosci Res 32:481-193, 1992.
56. Santell L, Marotti K, Bartfeld N, Baynham P, Levin E: Disruption of microtubules inhibits the stimulation of tissue plasminogen activator expression and promotes plasminogen activator inhibitor Type 1 expression in human endothelial cells. Exp Cell Res 201:358-365, 1992.
57. Scott C, Klica A, Lo M, Norris T, Caputo C: Tau protein induces bundling of microtubules in vitro: Comparison of different tau isoforms and a tau protein fragment. J Neurosci Res 33:19-29, 1992.
58. Sheridan V, Speicher L, Tew K: The effects of estramustine on metaphase and anaphase in DU 145 prostatic carcinoma cells. Eur J Cell Biol 54:268-276, 1991.
59. Speicher L, Barone L, Tew K: Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell line. Cancer Res 52:4433-4440, 1992.
60. Speicher L, Laing N, Barone L, Robbins J, Seamon K, Tew K: Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells. Mol Pharmacol 46:866-872, 1994.
61. Stearns M, Wang M, Sousa O: Evidence that estramustine binds MAP-1A to inhibit Type 4 collagenase secretion. J Cell Sci 98:55-63, 1991.
62. Tew K, Glusker J, Hartley-Asp B, Hudes G, Speicher L: Preclinical and clinical perspectives on the use of estramustine as an antimitotic drug. Pharmacol Ther 56:323-339, 1992.
63. von Shoultz E, Bergenheim T, Grankvist K, Henriksson R: Estramustine binding protein in human brain-tumor tissue. J Neurosurg 74:962-964, 1991.
64. Deleted in proof.
65. von Shoultz E, Grankvist K, Gustavsson H, Henriksson R: Effects of estramustine on DNA and cell membrane in malignant glioma cells. Acta Oncol 30:719-723, 1991.
66. von Schoultz E, Gunnarsson P, Henriksson R: Uptake, metabolism and antiproliferative effect of estramustine phosphate in human glioma cell lines. Anticancer Res 9:1713-1716, 1989.
67. von Schoultz E, Lundblad D, Bergh J, Grankvist K, Henriksson R: Estramustine-binding protein and antiproliferative effect of estramustine in human glioma cell lines. Br J Cancer 58:326-329,1988.
68. von Shoultz E, Lundgren E, Henriksson R: Effects of estramustine and its constituents on human malignant glioma cells. Anticancer Res 10:693-696, 1990.
69. Wallin M, Billger M, Slromberg T, Stromberg E: Assembly of Atlantic cod (Gndus morhua) brain microtubules at different temperatures: Dependency of microtubule-associated proteins is relative to temperature. Arch Biochem Biophys 307:200-205, 1993.
70. Wiche G: High-Mr microtubule-associated proteins: Properties and functions. Biochem J 259:1-11, 1989.
71. Yohem K, Clothier J, Montague S, Geary R, Winsters A, Hendrix M, Welch D: Inhibition of tumor cell invasion by verapamil. Pigment Cell Res 4:225-233, 1991.
72. Yoshida D, Cornell-Bell A, Piepmeier J: Selective antimitotic effects of estramustine correlate with its antimicrotubule properties on glioblastoma and astrocytes. Neurosurgery 34:867-868, 1994.
73. Yoshida D, Piepmeier J, Weinstein M: Estramustine sensitizes human glioblastoma cells to irradiation. Cancer Res 54:1415-1417, 1994.